Suchen
« Vorig |
1 - 10 von 36
|
Nächste »
Suchergebnisse
Select an image to start the slideshow
Design, Development and Application of a Novel In-Silico
High-throughput Screening Approach
1 of 10
Part I. Design of a novel class of reversible non-covalent small
molecule inhibitors for human Granzyme B (hGrB)
Part II. Curcumin and mimics as proteasome inhibitors
Part III. Design of novel coactivator binding inhibitors (CBIs)
for the estrogen receptor α : break the 1µM barrier
2 of 10
Optimization of Dual-tropic CXCR4/CCR5 HIV-1 Entry Inhibitors and a
Market Analysis
3 of 10
Towards the Development of Non-Toxic Therapeutics in the Fight
Against Cancer
4 of 10
Synthetic Studies Toward Cyclobutyl Nucleoside Analogs for the
Treatment of Hepatitis C Virus
5 of 10
Part I: Design, Synthesis and Biological Evaluation of C6-C8 Bridged Epothilone AnalogsPart II: Discovery of Small Molecule CXCR4 Antagonists
6 of 10
Computer-Assisted Drug Discovery Part I: Design, Development,
Validation and Application of FRESH, a Novel In-Silico
High-throughput Screening Program Part II: Monocarbonyl Curcumin
Analogues: Heterocyclic Pleiotropic Kinase Inhibitors that Mediate
Anticancer Properties Part III: Development of 2nd Generation
NAMFIS Software Program by Java
7 of 10
Design, Synthesis and Biological Evaluation of C4-C9 Bridged
Epothilone Analogs
8 of 10
Navigating the Roads to Drug Discovery: Part 1: Design, Synthesis,
and Biological Evaluation of a Novel Class of Allosteric Modulators
of N-Methyl-D-Aspartate Receptor Function Part 2: Discovery of
Novel Tetrahydroisoquinoline (THIQ)-Based CXCR4 Antagonists and
Conformational Analysis of Structurally Similar CXCR4 Antagonists
9 of 10
Design, Synthesis, and Biological Evaluation of Subunit-Selective
N-Methyl-D-Aspartate Receptor Modulators
10 of 10